| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.6 |